TIAA CREF Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

TIAA CREF Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$39.1M	Sell	760,622 -378,274	-33%	-$16.3M	0.03%	466
2018 Q4	$42.1M	Buy	1,138,896 +675,642	+146%	+$24.4M	0.03%	427
2018 Q3	$17.4M	Buy	463,254 +403,092	+670%	+$14.8M	0.01%	796
2018 Q2	$2.38M	Sell	60,162 -13,557	-18%	-$430K	﹤0.01%	2075
2018 Q1	$1.9M	Buy	73,719 +17,848	+32%	+$534K	﹤0.01%	2138
2017 Q4	$1.51M	Sell	55,871 -74,127	-57%	-$2.04M	﹤0.01%	2277
2017 Q3	$4.86M	Buy	129,998 +44,200	+52%	+$1.34M	﹤0.01%	1645
2017 Q2	$2.15M	Buy	+85,798	New	+$1.98M	﹤0.01%	2134

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TIAA CREF Investment Management's BHVN Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 33% in Q1 2019, selling an estimated $16.3M and leaving 760,622 shares worth $39.1M. The position accounts for 0.03% of the portfolio, ranked #466.

TIAA CREF Investment Management first reported a position in BHVN in Q2 2017 and has held it in 8 quarters since. The position peaked at $42.1M in Q4 2018. 170 funds tracked by Wall St. Rank hold BHVN as of Q1 2019.

TIAA CREF Investment Management held 760,622 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $39.1M as of Q1 2019.
TIAA CREF Investment Management sold 378,274 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2019, an estimated $16.3M.
Biohaven Pharmaceutical Holding Company Ltd. made up 0.03% of TIAA CREF Investment Management's portfolio in Q1 2019, its #466 holding.
TIAA CREF Investment Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and has held it in 8 quarters since.
TIAA CREF Investment Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $42.1M in Q4 2018.
170 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.